Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Europe close: Stocks mixed at start of short holiday week

(Sharecast News) - European markets finished in a mixed state on Monday, at the start of a shortened week ahead of Christmas and as global attention turned to news of a potential merger between Japanese auto giants Honda and Nissan. The pan-European Stoxx 600 rose 0.14%, closing at 502.91, while the FTSE 100 in London outperformed its peers, climbing 0.22% to 8,102.72.

In contrast, Germany's DAX declined 0.18% to settle at 19,848.77, and France's CAC 40 dipped slightly, slipping 0.03% to 7,272.32.

"Despite seeing the largest daily rally since early November on Friday, the S&P 500 ended its second straight week in the red amid higher US yields," said IG senior technical analyst Axel Rudolph.

"Asian markets followed Friday's US' lead and mostly ended the day in positive territory but European and US markets didn't follow suit.

"The UK economy stalled in the third quarter, following a downward revision from +0.1%, and German import prices rose for the first time in three months.

"This puts a damper on proceedings despite a higher Chicago Fed national activity index reading."

UK economy stagnates in third quarter, consumer confidence retreats stateside

In economic news, the UK economy stagnated in the third quarter, with no growth recorded according to revised figures from the Office for National Statistics (ONS).

That marked a downward adjustment from the previous estimate of 0.1% growth.

The ONS also lowered its estimate for second-quarter growth to 0.4% from 0.5%.

ONS also reported a mixed performance across sectors, with a 0.7% rise in construction offset by a 0.4% decline in production, while the services sector remained flat.

"The economy was weaker in the second and third quarters of this year than our initial estimates suggested with bars and restaurants, legal firms and advertising, in particular, performing less well," said Liz McKeown, director of economic statistics at the ONS.

"The household saving ratio fell a little in the latest period, though remains relatively high by historic standards. Meanwhile real household disposable income per head showed no growth."

Meanwhile, consumer confidence in the United States unexpectedly retreated in December, breaking a two-month streak of strong gains.

The Conference Board's consumer confidence index dropped to 104.7 from 112.8 in November, falling short of analysts' expectations for a slight increase.

That marked the first decline since September, as optimism tied to post-election momentum and improving economic conditions gave way to renewed concerns about the future.

The expectations index, a key indicator of outlook, fell sharply to 81.1, hovering just above the recession-warning threshold of 80, while the present situation index dipped slightly to 140.2.

Carmakers in focus on Honda-Nissan talks, Novo Nordisk rebounds

In equity markets, shares of Renault fell 1.2% on Monday following news that Nissan and Honda had signed a memorandum of understanding to discuss merging their operations.

The talks, which would take place over the next six months, were aimed at forming a joint holding company by August 2026.

Renault holds a stake of just under 16% in Nissan.

Sector peers Stellantis and Volkswagen also declined, with Stellantis down 0.29% and Volkswagen sliding 1.98%.

In the insurance sector, Aviva rose 0.52% after announcing it would acquire Direct Line Insurance Group for £3.75bn.

Direct Line shares surged 4.03% on the deal, which values the company at a 73.3% premium to its late-November price.

Aviva highlighted plans to save £125m annually through job cuts, economies of scale, and efficiency gains.

Elsewhere, Novo Nordisk rebounded sharply, rising 5.67%, after Friday's selloff erased $125bn from its market value.

The earlier decline followed disappointing results for its experimental obesity drug CagriSema.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Europe midday: Shares pare losses as investors digest China tariff move
(Sharecast News) - European stocks pared losses as investors digested China's retaliatory moves against US tariffs and the 30-day pause on levies against Canada and Mexico.
US pre-open: Futures slightly lower as tariff headlines remain in focus
(Sharecast News) - Wall Street futures were in the red ahead of the bell on Tuesday as the effects of the new White House administration's tariffs on a number of its closest trading partners continued to be seen.
Asia report: Markets bounce back from Trump tariff sell-off
(Sharecast News) - Asia-Pacific markets advanced on Tuesday as investor sentiment improved following Donald Trump's decision to pause tariffs on Mexico and Canada for a month.
London open: FTSE falls again as China retaliates against US
(Sharecast News) - London stocks were lower again in early trade on Tuesday following heavy losses a day earlier, after China announced retaliatory tariffs on a range of US imports.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.